To contribute to the development of the HR strategy in the respective Region´s donation
centers and play a key role in implementation and delivery through effective partnerships
with Divisional Management or General Managers.
Facilitate implementation/change process related to re-design and organizational changes,
to suit business needs ensuring HR processes are followed (meeting requirements) and
understood.
Bonus Program: Support management in defining critical objectives for their teams as
context for setting SMART objectives and facilitate the team engagement/alignment.
Merit Increase Program: Support management to ensure the best possible outcome when
implementing a merit pay program.
Benefits: Ensure they are consistent with HR Policies as defined by Country HR.
Promotions: Support management in the Promotion process to contribute to improve the
Company performance.
Operations Management: Ensure adherence to relevant labor and employment laws.
Coordinate with Country HR and transfer the impact on HR practice.
Consult with line management and provide daily HR guidance.
Resolve issues and address employees' grievances.
Work closely with management and employees to improve work relationships, build
morale and increase productivity and retention.
Support the implementation of HR policy and provide guidance around it.
Monitor and report on workforce and succession planning as necessary.
Identify training needs for teams and individuals as well as evaluating training program.
Grifols Egypt for plasma derivatives is a joint-venture (JV) company between the Egyptian Government, through the National Service Projects Organization (NSPO) and Grifols, the global leader in plasma medicines with more than 110 years of contribution to improving the health and well-being of people.
This joint venture is the first of its kind in the plasma industry and the first-ever Egyptian source member of the Plasma Protein Therapeutics Association (PPTA). GEPD is a groundbreaking global public-private alliance that will benefit the entire region.
GEPD is committed to developing the plasma medicines market and achieving self-sufficiency in these critical therapies, which is crucial for the Egyptian healthcare system.
We are combining the expertise of both shareholders to build and operate 20 plasma donation centers throughout Egypt, along with manufacturing facilities including fractionation, purification, and fill-and-finish plants with a processing capacity of up to 1 million liters of plasma annually that can double in the future.
The new manufacturing facility will include a plasma warehouse and a testing laboratory. It will occupy 105,000 square meters strategically located in the administrative capital’s medical city, adjoining various healthcare institutions.
